Symptoms and the Path Ahead: What to Expect Over Time
At a Glance
SSADHD usually does not cause ongoing loss of skills, but its symptoms can change as a child grows. Language, movement, behavior, sleep, and seizures may follow different patterns, so any new loss of skills, weakness, confusion, or major change needs prompt medical evaluation.
Understanding how Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) changes over time can help you prepare for the different stages of your child’s life. While the condition is generally nondegenerative—meaning the underlying brain condition does not typically cause a continuous loss of skills—the way it shows up (the phenotype) often shifts as a child grows [1][2].
Important Note: Because every child is unique, no single patient will follow an “average” trajectory perfectly. The information below comes from observational cohorts and represents common patterns, not strict predictions.
Early Signs in Infancy
In many reported cases, early signs of SSADHD appear in the first year of life, often around 6 months of age [1]. The most common early symptoms include:
- Hypotonia: This is the medical term for low muscle tone, often described as a baby feeling “floppy” when held [1][3].
- Developmental Delays: A child may be slower to reach major milestones, such as holding their head up, sitting without support, or rolling over [2].
Language and Cognitive Impact
In observational cohorts, a majority of children with SSADHD experience some degree of intellectual disability and delays in adaptive skills (the practical skills needed for daily life) [4].
Language is usually more affected than physical movement [2]. Specifically, there is often a gap between:
- Receptive Language: What a child understands.
- Expressive Language: What a child can say or communicate [4].
In many patients, expressive language is significantly more impaired. This means your child may understand much more of what you are saying than their ability to speak would suggest [4][5].
Movement and Coordination
As children grow, a variety of movement-related issues may become apparent. These involve different motor circuits in the brain, such as the cerebellum (which coordinates movement) and the basal ganglia [1].
- Ataxia: A cerebellar sign that looks like clumsiness, a shaky gait, or poor balance [1].
- Dystonia and Chorea: Movement disorders often linked to the basal ganglia, involving involuntary muscle contractions, rigid postures, or irregular, “dance-like” twitching [1].
- Hypokinesia: A slowness of movement or reduced physical activity [1].
While these issues are common, natural history studies report that motor function and communication often tend to show improvement as children move through childhood and into adolescence [2][5].
Behavioral and Psychiatric Symptoms
While motor skills often improve with age, behavioral and psychiatric challenges tend to become more prominent as a child gets older [5]. These can include:
- Attention Issues: High rates of distractibility and short attention spans are commonly observed [4][1].
- Anxiety and OCD: Many patients develop significant anxiety or obsessive-compulsive behaviors (the need for rigid routines or repetitive actions) [6][7].
- Sleep Disturbances: Problems falling or staying asleep often emerge or worsen [6].
- Rare Symptoms: In a small number of cases, symptoms like psychosis have been noted in late adolescence or early adulthood [8].
The Trajectory of Epilepsy
Epilepsy affects approximately 50% of people with SSADHD [9]. The timing and type of seizures can follow an age-related pattern, though it varies widely:
- Absence Seizures: These “staring spells” are reported to begin in early childhood (median onset around age 2 in some cohorts) [6].
- Generalized Seizures: Larger, tonic-clonic seizures may appear later (median onset around age 12 in some cohorts) [6].
In contrast to motor skills, seizure severity and frequency can increase with age in some individuals [9][6]. Some adults may develop drug-resistant seizures, making an ongoing relationship with a neurologist essential.
When to Seek Immediate Evaluation
Because SSADHD is generally nondegenerative, an apparent regression or sudden decline in skills is a red flag. Always seek prompt medical evaluation for:
- Loss of previously acquired skills (motor or speech)
- New, unexplained weakness
- Prolonged confusion
- A major change in baseline abilities after an illness
Knowing these general patterns allows you to work proactively with your child’s medical team to adjust treatments and support systems as they transition into adulthood.
Common questions in this guide
What are the first signs of SSADHD in a baby?
Does SSADHD cause a steady loss of skills over time?
Why might a child with SSADHD understand more than they can say?
What movement problems can occur as a child with SSADHD grows?
What behavioral or sleep changes are common in older children with SSADHD?
What types of seizures can occur with SSADHD?
When should a child with SSADHD be evaluated urgently?
Get notified when new evidence is published on Succinic semialdehyde dehydrogenase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency.
Julia-Palacios NA, Kuseyri Hübschmann O, Olivella M, et al.
Journal of inherited metabolic disease 2024; (47(3)):447-462 doi:10.1002/jimd.12723.
PMID: 38499966 - 2
Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder.
Tokatly Latzer I, Roullet JB, Afshar-Saber W, et al.
Journal of neurodevelopmental disorders 2024; (16(1)):21 doi:10.1186/s11689-024-09538-9.
PMID: 38658850 - 3
Acute Infantile Encephalopathy as Presentation of Succinic Semialdehyde Dehydrogenase Deficiency.
Zeiger WA, Sun LR, Bosemani T, et al.
Pediatric neurology 2016; (58()):113-5.
PMID: 27268762 - 4
The neuropsychological profile of SSADH deficiency, a neurotransmitter disorder of GABA metabolism.
Tokatly Latzer I, Hanson E, Bertoldi M, et al.
Molecular genetics and metabolism 2025; (144(3)):109051 doi:10.1016/j.ymgme.2025.109051.
PMID: 39919676 - 5
Establishment and validation of a clinical severity scoring system for succinic semialdehyde dehydrogenase deficiency.
Tokatly Latzer I, Roullet JB, Gibson KM, Pearl PL
Journal of inherited metabolic disease 2023; (46(5)):992-1003 doi:10.1002/jimd.12635.
PMID: 37219411 - 6
Age-related phenotype and biomarker changes in SSADH deficiency.
DiBacco ML, Roullet JB, Kapur K, et al.
Annals of clinical and translational neurology 2019; (6(1)):114-120 doi:10.1002/acn3.696.
PMID: 30656189 - 7
Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood.
Lapalme-Remis S, Lewis EC, De Meulemeester C, et al.
Neurology 2015; (85(10)):861-5 doi:10.1212/WNL.0000000000001906.
PMID: 26268900 - 8
The characterization of psychotic symptoms in succinic semialdehyde dehydrogenase deficiency: a review.
Colijn MA
Psychiatric genetics 2020; (30(6)):153-161 doi:10.1097/YPG.0000000000000264.
PMID: 33165204 - 9
The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency.
Tokatly Latzer I, Bertoldi M, DiBacco ML, et al.
Epilepsia 2023; (64(6)):1516-1526 doi:10.1111/epi.17592.
PMID: 36961285
This page describes common SSADHD symptom patterns for informational purposes only and does not constitute medical advice or predict your child’s course. Contact your child’s healthcare professional promptly about regression, new weakness, prolonged confusion, or a major change in abilities.